Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2006
12/21/2006WO2006134056A1 Process for the identification of novel enzyme interacting compounds
12/21/2006WO2006133931A2 Identification of jak/stat pathway modulating genes by genome wide rnai screening
12/21/2006WO2006133878A2 Methods and devices for controlling the impact of short circuit faults on co-planar electrochemical sensors
12/21/2006WO2006133752A1 Circuit for detecting combustion-related variables
12/21/2006WO2006133738A1 Reduction of pressure induced temperature influence on the speed of sound in a gas
12/21/2006WO2006133728A1 Tissue paper with ph-indicator function
12/21/2006WO2006133691A1 Method for determining and influencing the fertility of male mammals and of a human being
12/21/2006WO2006133584A1 Method and device for detecting foreign matter in a moving solid elongated test object
12/21/2006WO2006133568A1 Virtual mass spectrometry
12/21/2006WO2006133560A1 Psp94 diagnostic reagents and assays
12/21/2006WO2006133555A1 Psychotropic drug screening device based on long-term photoconductive stimulation of neurons
12/21/2006WO2006133496A1 Malting process
12/21/2006WO2006133476A2 Enzyme array
12/21/2006WO2006123949A3 Sample holder
12/21/2006WO2006119265A3 Xenograft tissue control for histology
12/21/2006WO2006119264A3 Antibodies against histone modifications for clinical diagnosis and prognosis of cancer
12/21/2006WO2006116016A3 Molecular determinants of egfr kinase inhibitor response in glioblastoma
12/21/2006WO2006114611A3 Materials and methods relating to the diagnosis of cancer
12/21/2006WO2006113915A3 Ultrasensitive detection of prions by automated protein misfolding cyclic amplification
12/21/2006WO2006113599A3 Methods of diagnosing inflammatory diseases of intestine
12/21/2006WO2006113352A3 Implantable biosensor comprising transgenic mammalian cells
12/21/2006WO2006113347A3 Diagnostic and therapeutic potential of immune globulin intravenous (igiv) products
12/21/2006WO2006110585A3 Cancer-related genes (prlr)
12/21/2006WO2006109044A3 Selective modulation of tumour necrosis factor receptors in therapy
12/21/2006WO2006108718B1 Micro rna
12/21/2006WO2006107198A3 Production of unconjugated oligosaccharides by pathogens
12/21/2006WO2006105519A3 Protein microarray system
12/21/2006WO2006100096A3 Methods to identify and characterize prolyl oligo-peptidases by using substrates and products thereof
12/21/2006WO2006099579A3 Compositions and methods for clonal amplification and analysis of polynucleotides
12/21/2006WO2006099493A3 Rapidly detecting and quantifying viable legionella
12/21/2006WO2006097336A3 A novel component of the wg/wnt signaling pathway
12/21/2006WO2006096835A3 Monitoring and manipulating cellular transmembrane potentials using nanostructures
12/21/2006WO2006096614A3 Angiogenic heparin binding peptide amphiphiles
12/21/2006WO2006091773A3 Compositions and methods related to serpin spi6
12/21/2006WO2006089125A3 Methods of detecting ovarian cancer
12/21/2006WO2006089009A3 Methods and compositions for the treatment of lipid-associated disorders
12/21/2006WO2006088803A3 Polypeptides from staphylococcus aureus and methods of use
12/21/2006WO2006087533A3 Ricin-binding peptides and methods for use thereof
12/21/2006WO2006086748A3 Genetic markers in the csf2rb gene associated with an adverse hematological response to drugs
12/21/2006WO2006085121A3 Vgp peptide fragments as biomarkers for schizophrenic and bipolar disorders
12/21/2006WO2006084130A3 Ultra-sensitive detection systems using multidimension signals
12/21/2006WO2006083907A3 Method and apparatus for sorting cells
12/21/2006WO2006080186B1 Detection device using cartridge
12/21/2006WO2006078733A3 Estrogen receptor structure
12/21/2006WO2006078271A3 Cloning and expression of the full length 110 kda antigen of orientia tsutsugamushi to be used as a vaccine component against scrub typhus
12/21/2006WO2006076025A3 Immune cell biosensors and methods of using same
12/21/2006WO2006073447A3 Enriched pag-55 fraction and methods for early detection of pregnancy in ungulate animals
12/21/2006WO2006044017A3 Systems and methods for identifying diagnostic indicators
12/21/2006WO2006022895A3 Platelet biomarkers for cancer
12/21/2006WO2006015195A8 Methods for determining the potency, specificity, and toxicity of hematopoietic prostaglandin d2 synthase
12/21/2006WO2006010047A3 Methods and compositions for the detection of ovarian cancer
12/21/2006WO2005124351A8 A sensitive antibody-based method for detecting cryptosporidium parvum oocysts in water
12/21/2006WO2005121172A8 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
12/21/2006WO2005116644A8 Method of evaluation of the relative risk of developing atherosclerosis in patients
12/21/2006WO2005114221A3 Compositions and methods for quantification of serum glycoproteins
12/21/2006WO2005111613A3 Methods of identifying apoptotic cells
12/21/2006WO2005103281A9 Platelet biomarkers for the detection of disease
12/21/2006WO2005098439A3 Lateral flow format, materials and mehtods
12/21/2006WO2005062967A3 Novel anti-il 13 antibodies and uses thereof
12/21/2006WO2005016127A3 Prion-specific peptide reagents
12/21/2006WO2004096153A3 Prostate cancer therapeutics and diagnostics based on conformers of prostatic acid phosphatase
12/21/2006WO2004078143A3 Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
12/21/2006WO2004069184A3 Methods for treating, preventing and detecting helicobacter infection
12/21/2006WO2002087306A3 High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
12/21/2006US20060288434 Inhibiting angiogenesis in a mammal by administering an antibody which specifically binds to EphriniB2 or EphB4; cardiovascular disorders
12/21/2006US20060288248 Information processing apparatus with adjustable system clock
12/21/2006US20060287513 Compositions and methods for the therapy and diagnosis of breast cancer
12/21/2006US20060287509 isolated nucleic acid encoding a human antibody that specifically binds to C-ERBB-2 protein product of HER2/NEU oncogene; for diagnosis of cancer/tumors which over express this gene; for immunotoxins and other antitumor/anticarcinogenic agents; less immunogenic
12/21/2006US20060287503 Analyzing fusion protein expression; biological screening
12/21/2006US20060287502 C3b/C4b complement receptor-like molecules and uses thereof
12/21/2006US20060287501 Soluble truncated polypeptides of the nogo-a protein
12/21/2006US20060287372 Pharmaceutical preparations containing thiazolidinediones showing new therapeutic indications
12/21/2006US20060287279 Method of assaying an Fe-sugar complex
12/21/2006US20060287227 Gonadal function improving agents
12/21/2006US20060287226 Characterization of a membrane estrogen receptor
12/21/2006US20060286685 For detecting an analyte in a sample includes a resonant sensor that has a sensor surface coated with the capture agent; sensors for detecting analyte in liquid samples
12/21/2006US20060286684 Sensors for detecting an analyte using silver nanoparticles
12/21/2006US20060286683 Method and testing system for analyzing and/or detecting biomolecules and/or active substances in liquid samples
12/21/2006US20060286682 Surface treatment
12/21/2006US20060286681 Proximal markers of arterial thrombosis and inflammation for risk stratification of coronary heart disease
12/21/2006US20060286680 Fiber-optic biosensor and biosensing methods
12/21/2006US20060286679 Immunochromatographic method
12/21/2006US20060286675 Using variation in electrical resistance of hydrocarbon fuel as tool in determining potential for water or water-based phase to form in fuel during transportation or storage
12/21/2006US20060286674 Method and device for an accelerated oxidation test of fuels or petroleum products, as well as a computer program for controlling such a device, and a corresponding computer readable storage medium
12/21/2006US20060286673 Amino acid or peptide in sample with labels to form carbamate and isotopes
12/21/2006US20060286672 A catalytic conformational sensor method; catalyzes transformation of the probe to a predominately beta sheet conformation and allows the probe to bind to the abnormal proteinaceous particle; Alzheimer's Disease, Huntington's Disease, and prion-associated diseases
12/21/2006US20060286670 Transplant acceptance inducing cells of monocytic origin and their preparation and use
12/21/2006US20060286663 Method for producing a colorimetric resonant reflection biosensor on rigid surfaces
12/21/2006US20060286662 Medical diagnostic test strip
12/21/2006US20060286627 Methods and kits for obtaining a metabolic profile of living animal cells
12/21/2006US20060286619 Device for performing analyses on biological fluids and related method
12/21/2006US20060286617 PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
12/21/2006US20060286616 Menopause stage monitor
12/21/2006US20060286615 Novel non-invasive marker for liver function and disease
12/21/2006US20060286614 Monitoring effective thrombin levels in patients undergoing anticoagulant therapy; measuring circulating levels of soluble endothelial protein C receptor (sEPCR)
12/21/2006US20060286613 Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase
12/21/2006US20060286612 Spore specific antibodies
12/21/2006US20060286611 Antibodies against biotinylated histones and related proteins and assays related thereto
12/21/2006US20060286610 Identification of ligands by selective amplification of cells transfected with receptors
12/21/2006US20060286609 Rabbit monoclonal antibody against Id1 protein